Aschenberg W, Nienaber C, Spielmann R, Bleifeld W
Abteilung für Kardiologie, Universitäts-Krankenhaus Eppendorf, Hamburg.
Z Kardiol. 1988 Apr;77(4):238-44.
Calcium channel blockers of the dihydropyridine type have different sites of action that may cause negative inotropic effects in some patients; therefore, their use as systemic vasodilators in left heart failure may be limited. In 10 patients with coronary heart disease we compared the acute peripheral and central hemodynamic effects of i.v. nisoldipine vs. i.v. nifedipine intraindividually, using a sequential crossover protocol. All patients were subjected to right heart catheterization, arterial pressure monitoring, and simultaneous radionuclide angiography. The infusion of either calcium channel blocker was titrated to a similar steady-state reduction of mean arterial pressure by 15 +/- 3% and 15 +/- 2%, respectively, which reduced systemic vascular resistance by 25 +/- 5% and 17 +/- 2%, respectively. The required equally effective dosage was 0.17 +/- 0.06 micrograms/min/kg for nisoldipine and 0.58 +/- 0.1 micrograms/min/kg for nifedipine. In contrast to nifedipine, the administration of nisoldipine was associated with an increase in cardiac index by 0.45 +/- 0.33 l/min/m2 (p less than 0.05), stroke volume index by 3.91 +/- 3.0 ml/m2 (p less than 0.05), and left ventricular ejection fraction by 4.6 +/- 2.8% (p less than 0.05). Mean pulmonary capillary wedge pressure decreased with nisoldipine from 11.8 +/- 3.4 to 8.0 +/- 3.4 mm Hg (p less than 0.005) and mean pulmonary artery pressure decreased from 20.4 +/- 4.06 to 16.1 +/- 3.2 mm Hg (p less than 0.005), but was unaffected by nifedipine. Left and right ventricular endsystolic and enddiastolic volumes were not significantly altered by either drug.(ABSTRACT TRUNCATED AT 250 WORDS)
二氢吡啶类钙通道阻滞剂具有不同的作用位点,在某些患者中可能会引起负性肌力作用;因此,它们在左心衰竭中作为全身血管扩张剂的应用可能受到限制。在10例冠心病患者中,我们采用序贯交叉方案,对静脉注射尼索地平与静脉注射硝苯地平的急性外周和中心血流动力学效应进行了个体内比较。所有患者均接受右心导管检查、动脉压监测和同步放射性核素血管造影。分别将两种钙通道阻滞剂的输注量滴定至使平均动脉压类似地稳定降低15±3%和15±2%,这分别使全身血管阻力降低25±5%和17±2%。尼索地平的等效有效剂量为0.17±0.06微克/分钟/千克,硝苯地平为0.58±0.1微克/分钟/千克。与硝苯地平相反,尼索地平给药后心脏指数增加0.45±0.33升/分钟/平方米(p<0.05),每搏量指数增加3.91±3.0毫升/平方米(p<0.05),左心室射血分数增加4.6±2.8%(p<0.05)。尼索地平使平均肺毛细血管楔压从11.8±3.4降至8.0±3.4毫米汞柱(p<0.005),平均肺动脉压从20.4±4.06降至16.1±3.2毫米汞柱(p<0.005),但硝苯地平对此无影响。两种药物对左、右心室收缩末期和舒张末期容积均无明显改变。(摘要截选至250字)